Contributing Experts

December 15, 2011

Emanuel Petricoin, Ph.D.

Dr. Emanuel F Petricoin has been the Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University since 2005, where he is a University Professor.

Prior to this position, he served as Co-Director of the FDA-NCI Clinical Proteomics Program from 2001-2005, and a Senior Investigator within the Center for Biologics Evaluation and Research at the US Food and Drug Administration from 1993-2005. Dr. Petricoin received his Ph.D. in Microbiology from the University of Maryland in 1990.

The focus of the CAPMM is the invention and use of proteomics technologies for signal transduction analysis, phosphoproteomics and nanoparticle-based peptidomic biomarker discovery for direct clinical applications at the bedside. He and his colleague, Dr. Lance Liotta, have recently spun-out two companies based on technologies and discoveries made in their GMU laboratories.

The first company, Theranostics Health, was founded in 2006, and focuses on personalized therapy. Dr. Petricoin serves as Chair of the Scientific Advisory Board for the company. The second company, Ceres Nanosciences, was founded in 2008, and focuses on the use of a novel nanoparticle technology for early disease detection and measurement of ultra low abundance proteins for clinical applications. He is on the Scientific Advisory Board for Ceres.

Dr. Petricoin is a co-inventor on 40 filed and published patents and has authored over 280 peer-reviewed publications and invited reviews. He has authored over 40 book chapters, is the Co-Editor-in-Chief of Human Genomics and Proteomics, is on the editorial board of Proteomics, Biomedical Microdevices, Proteomics- Clinical Applications, Proteomics- Protocols, Molecular Carcinogenesis, Journal of Personalized Medicine and is a Senior Editor for Cancer Epidemiology Biomarkers and Prevention. He was the founding Co-Editor-in-Chief of Clinical Proteomics.

Dr. Petricoin is a founding member of the Human Proteomic Organization (HUPO) as well as the US HUPO, and served on the Executive Committee and Treasurer for HUPO from 2002-2004. He has received numerous awards including the George Mason University Professorship, the NIH Director’s Award, FDA Distinguished Scientist Award, American Society of Cytopathology Basic Research Award, the Roche Diagnostics/CLAS Distinguished Scientist Award and the Harvard University Leading Edge Award.

Last Updated: October 8, 2012